Friday, Nov 22 2019 | Time 13:20 Hrs(IST)
image
  • Every person in Lahore at risk due to smog, says Amnesty International
  • US House speaker casts doubt on passing USMCA deal this year
  • Sri Lanka Prez appoints new 16 member cabinet
  • CBI raids residences of Former CM Ibobi
  • Govt taking initiatives to ensure sound management of plastic waste: Javadekar
  • Bangladesh win toss & decide to bat first at historic D/N pink ball test against India at Eden
  • Senior journalist Nilkanth Khadilkar dies after a brief illness
  • Prince Rajbhar, injured in Mumbai hospital ICU fire, passes away
  • Hasina arrives in Kolkata to inaugurate India's maiden historic D/N Test at Eden
  • Hasina arrives Kolkata to inaugurate India's maiden historic D/N Test at Eden
  • Rupee rises 5 paise against USD
  • Iraq protests claim 9 lives in less than week: HRC
  • UP Law Commission suggest stringent punishment for conversion
  • Japan’s to host G20 foreign ministers’ meeting on November 22-23
  • Imran, Trump discuss Afghan peace process, Kashmir over phone
Business Economy


Dr Reddy's announces launch of Fosaprepitant for Injection in US Market

Dr Reddy's announces launch of Fosaprepitant for Injection in  US Market

Hyderabad, Sep 11 (UNI) Dr Reddy’s Laboratories Limited on Wednesday announced the launch of therapeutic generic equivalent of Emend (fosaprepitant) for injection, approved by the US Food and Drug Administration (USFDA).



“We are pleased to be among the first generics to launch this product,” explained Marc Kikuchi, Chief Executive Officer, North America Generics, Dr Reddy’s Laboratories.

“This is a great addition to our injectable portfolio in the US market as we continue to augment our product offering and drive growth for the hospital segment,” he said.



The Emend for Injection brand had an US sales of approximately USD 279 million MAT for the most recent twelve months ending in July 2019 according to IQVIA Health, a company statement here said .



Dr Reddy’s Fosaprepitant for Injection is available in 150 mg single-dose vial for reconstitution.

UNI VV CS 1625

More News
Rupee rises 5 paise against USD

Rupee rises 5 paise against USD

22 Nov 2019 | 12:02 PM

Mumbai, Nov 22 (UNI) The Rupee on Friday moved up five paise to 71.

see more..

Chennai Oil Market Rates

22 Nov 2019 | 11:48 AM

Chennai, Nov 22 (UNI) Following are the rates in the
Chennai Oil Market here today.

see more..
Sensex up by 78 pts

Sensex up by 78 pts

22 Nov 2019 | 11:42 AM

Mumbai, Nov 22 (UNI) The benchmark index of Bombay Stock Exchange (BSE) on Friday advanced by 78 points to open at 40,653.17 on renewed buying in Materials, Energy, FMCG, Auto and Health Care. While, the Nifty of National Stock Exchange (NSE) opened negative at 11,967.30, easing by 1 point.

see more..
Bullion Market Opening Rates

Bullion Market Opening Rates

22 Nov 2019 | 11:05 AM

Chennai, Nov 22 (UNI) Following is the bullion markets
opening rate here today.

see more..

DBS Bank to set up 30 more touchpoints across 25 cities in India in next 6-12 months

21 Nov 2019 | 7:01 PM

Hyderabad, Nov 21 (UNI) DBS Bank India Limited (DBIL), the wholly owned subsidiary of DBS Bank Limited.

see more..
image